Smartlens
PrivateLast Round
VC Round
Oct 14, 2025
Total Funding Raised
$6.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Smartlens operates in Healthcare & Life Sciences and is based in Sunnyvale, California. Its latest recorded funding round was a VC Round in October 2025.
Smartlens is a healthcare technology company that develops a microfluidic-based smart contact lens and AI-powered smartphone app to monitor intraocular pressure and prevent the progression of glaucoma and irreversible blindness.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Smartlens Comparables
Compare Smartlens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BVS Sight, Inc. | 90% | |
| GlakoLens | 87% | |
| Injectsense, Inc. | 86% |
For institutional investors. Book with your work email.
Smartlens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 14, 2025 | ||||
| Series A | Jul 11, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Smartlens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wilson Sonsini Investments | Series A |
| Bencao Capital | Series A |
| Stanford University | Series A |
| Boutique Venture Partners | VC Round, Series A |
| Ambit Health Ventures | VC Round, Series A |
| Harvard Business School Alumni Angels of Greater New York | VC Round |
| Plaisance Capital Management | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 100% MoM, reaching 3.9K.
- Oct 14, 2025
$5.2M raised in debt financing.
For institutional investors. Book with your work email.
Smartlens Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Smartlens's valuation, stock price, and market status.
Is Smartlens a public or private company?
Smartlens is a private company.
What is the current stock price of Smartlens?
Smartlens is a private company, so its shares have no public market price. Caplight tracks Smartlens's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Smartlens worth (valuation)?
Valuation information for Smartlens is not publicly available.
Can I buy Smartlens stock?
Smartlens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Smartlens's last funding round?
Smartlens's most recent funding round was VC Round on October 14, 2025.
Who are the main investors in Smartlens?
Key investors in Smartlens include Ambit Health Ventures.
Will Smartlens IPO soon?
No public IPO plans have been announced for Smartlens.
How can I track Smartlens secondary market activity?
Caplight tracks bids, offers, and trades in Smartlens's shares on secondary markets.